BRUSSELS and SAN DIEGO, Jan. 21, 2019 /PRNewswire/ — The Center for Beta Cell Therapy in Diabetes, coordinator of an international consortium in translational medicine in diabetes, and ViaCyte, Inc., a privately held regenerative medicine company,… […]
SAN DIEGO, Jan. 18, 2019 /PRNewswire/ — Biocept, Inc. (NASDAQ: BIOC) (“Biocept” or the “Company”), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of… […]
SAN DIEGO, Jan. 16, 2019 /PRNewswire/ — Mirati Therapeutics, Inc. (Nasdaq: MRTX) today announced that it intends to offer and sell, subject to market and other conditions, $75.0 million of shares of its common stock in an underwritten public offeri… […]
CARLSBAD, Calif., Jan. 16, 2019 /PRNewswire/ — Applied Spectral Imaging (ASI), a global leader and provider of biomedical imaging analysis solutions has launched a new product update to facilitate the growing demands of pathology and cytogenetic la… […]
CUMBERLAND, R.I. and LA JOLLA, Calif., Jan. 16, 2019 /PRNewswire/ — The results of the NT-501 Phase 2 study sponsored by Neurotech Pharmaceuticals, Inc. (Neurotech) in collaboration with the Lowy Medical Research Institute (LMRI), have been publish… […]
-Diagnostic can detect activated RSK2, a prime target in TNBC, in breast cancer patients-
VANCOUVER, British Columbia and SAN DIEGO, Jan. 16, 2019 /PRNewswire/ — Phoenix Molecular Designs (PhoenixMD), a privately-held biotechnology company designing… […]
SAN DIEGO, Jan. 15, 2019 /PRNewswire/ — Trovagene, Inc. (Nasdaq: TROV), a clinical-stage oncology therapeutics company, taking a precision cancer medicine approach to develop drugs that target cell division (mitosis) for the treatment of leukemias,… […]
SAN DIEGO, Jan. 15, 2019 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology company, announced today that it has dosed the first patient in a Phase 1/2 clinical trial of MRTX849, an investigational KRAS G12C… […]
Conference Call and Webcast Scheduled for Tuesday, February 5
SAN DIEGO, Jan. 15, 2019 /PRNewswire/ — Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it will report fourth quarter and year-end 2018 financial results after the Nasdaq… […]
AmMag SA magnetic purification system first to offer high throughput of large samples, accelerating early stage drug development
SAN DIEGO, Jan. 14, 2019 /PRNewswire/ — GenScript®, the world’s leading gene synthesis provider, announced today at PepT… […]
Copyright © 2019 San Diego Biotechnology Network (DBA of Comprendia. LLC)
